134 related articles for article (PubMed ID: 37946492)
1. Cardiovascular Safety of the COVID-19 Vaccine in Team USA Athletes.
Shah AB; Rizzo SM; Finnoff JT; Baggish AL; Adams WM
Sports Health; 2024; 16(4):504-506. PubMed ID: 37946492
[TBL] [Abstract][Full Text] [Related]
2. Investigation of supplement use and knowledge among Japanese elite athletes for the Tokyo 2020 Olympic/Paralympic games and the Beijing 2022 winter Olympic/Paralympic games.
Myoenzono K; Yasuda J; Takai E; Shinagawa A; Kaneko N; Yoshizaki T; Namma-Motonaga K; Yoshino M; Kondo E; Nakajima K; Hangai M; Kamahara K; Kamihigashi E; Kusano S; Kamei A
Front Sports Act Living; 2023; 5():1258542. PubMed ID: 37927448
[TBL] [Abstract][Full Text] [Related]
3. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
4. Incidence of injury and illness among paediatric Team USA athletes competing in the 2020 Tokyo and 2022 Beijing Olympic and Paralympic Games.
Post EG; Anderson T; Shilt JS; Dugan EL; Clark SC; Larson EG; Noble-Taylor KE; Robinson DM; Donaldson AT; Finnoff JT; Adams WM
BMJ Open Sport Exerc Med; 2023; 9(4):e001730. PubMed ID: 38143720
[TBL] [Abstract][Full Text] [Related]
5. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
[TBL] [Abstract][Full Text] [Related]
7. Team USA injury and illness incidence at the 2022 Beijing Winter Olympic and Paralympic Games.
Anderson T; Cali MG; Clark SC; Hasley I; Larson EG; Noble-Taylor KE; Robinson DM; Post E; Finnoff JT; Adams WM
Br J Sports Med; 2023 Oct; ():. PubMed ID: 37890965
[TBL] [Abstract][Full Text] [Related]
8. Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation.
Daems JJN; van Hattum JC; Verwijs SM; Bijsterveld NR; Groenink M; Wilde AAM; Pinto YM; Jorstad HT
Br J Sports Med; 2023 Nov; 57(21):1400-1402. PubMed ID: 37562938
[TBL] [Abstract][Full Text] [Related]
9. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
[TBL] [Abstract][Full Text] [Related]
12. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
[TBL] [Abstract][Full Text] [Related]
13. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
[TBL] [Abstract][Full Text] [Related]
14. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
[TBL] [Abstract][Full Text] [Related]
15. Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years.
Hu M; Wong HL; Feng Y; Lloyd PC; Smith ER; Amend KL; Kline A; Beachler DC; Gruber JF; Mitra M; Seeger JD; Harris C; Secora A; Obidi J; Wang J; Song J; McMahill-Walraven CN; Reich C; McEvoy R; Do R; Chillarige Y; Clifford R; Cooper DD; Shoaibi A; Forshee R; Anderson SA
JAMA Pediatr; 2023 Jul; 177(7):710-717. PubMed ID: 37213095
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
Wong HL; Hu M; Zhou CK; Lloyd PC; Amend KL; Beachler DC; Secora A; McMahill-Walraven CN; Lu Y; Wu Y; Ogilvie RP; Reich C; Djibo DA; Wan Z; Seeger JD; Akhtar S; Jiao Y; Chillarige Y; Do R; Hornberger J; Obidi J; Forshee R; Shoaibi A; Anderson SA
Lancet; 2022 Jun; 399(10342):2191-2199. PubMed ID: 35691322
[TBL] [Abstract][Full Text] [Related]
17. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
18. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
Lane S; Yeomans A; Shakir S
BMJ Open; 2022 May; 12(5):e059223. PubMed ID: 35613761
[TBL] [Abstract][Full Text] [Related]
19. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
Kracalik I; Oster ME; Broder KR; Cortese MM; Glover M; Shields K; Creech CB; Romanson B; Novosad S; Soslow J; Walter EB; Marquez P; Dendy JM; Woo J; Valderrama AL; Ramirez-Cardenas A; Assefa A; Campbell MJ; Su JR; Magill SS; Shay DK; Shimabukuro TT; Basavaraju SV;
Lancet Child Adolesc Health; 2022 Nov; 6(11):788-798. PubMed ID: 36152650
[TBL] [Abstract][Full Text] [Related]
20. Incidence of staff injury and illness at the Tokyo 2020 and Beijing 2022 Olympic and Paralympic Games.
Larson EG; Hasley I; Post EG; Cali MG; Clark SC; McPherson AL; Noble-Taylor KE; Robinson DM; Anderson T; Finnoff J; Adams WM
BMJ Open Sport Exerc Med; 2024; 10(2):e001835. PubMed ID: 38645762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
